|Bid||144.75 x 800|
|Ask||145.06 x 1000|
|Day's range||144.30 - 149.18|
|52-week range||139.20 - 254.34|
|Beta (5Y monthly)||1.11|
|PE ratio (TTM)||16.13|
|Earnings date||02 Feb 2022|
|Forward dividend & yield||2.64 (1.66%)|
|Ex-dividend date||26 Nov 2021|
|1y target est||203.13|
The recent ruling by the South Dakota Supreme Court that struck down a voter referendum approving legalized marijuana shows the difficult road ahead for cannabis stocks in dealing with state-by-state approvals. Alex Carchidi (Scotts Miracle-Gro): I'd be willing to buy a few shares of Scotts Miracle-Gro (NYSE: SMG) without hesitation because it's a highly diversified business that makes the gardening tools and plant nutrients that marijuana growers need to keep making money.
Scotts Miracle-Gro's (SMG) Q4 results are impacted by lower sales in all the segments.
SMG earnings call for the period ending September 30, 2021.